South Broward Hospital District

South Broward Hospital District was paid $81.73M by Medicaid between Jan 2018 and Dec 2024, across 566 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.

33Billing provider infoSOUTH BROWARD HOSPITAL DISTRICT
HOLLYWOOD, FL 33021

33aNPI1780667923assigned 11/22/2005

33bProvider typeEmergency Medicine Physician

28Total paid$81.73M

24GClaims2,556,667

24DCodes billed566

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Emergency Medicine Physician providers in Florida

Rank by total paid#1 of 391

Median peer was paid$61K

This provider vs. median1,340×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	186,110	$4.44M
2019	551,675	$17.32M
2020	411,564	$9.90M
2021	446,288	$12.28M
2022	541,301	$18.56M
2023	279,147	$12.12M
2024incomplete	140,582	$7.10M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	16%	146,018	132,760	$13.31M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	10%	109,630	92,257	$8.57M
99282	Emergency department visit for the evaluation and management, low to moderate severity	10%	80,356	74,631	$8.37M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	4.0%	29,676	7,187	$3.26M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.3%	39,960	9,103	$2.72M
41899	Unlisted procedure, dentoalveolar structures	2.8%	5,261	4,887	$2.30M
97530	Therapeutic activities, direct patient contact, each 15 minutes	2.6%	25,135	5,864	$2.09M
80053	Comprehensive metabolic panel	1.9%	94,904	71,647	$1.56M
96361	Intravenous infusion, hydration; each additional hour	1.7%	17,639	11,577	$1.35M
70450	Computed tomography, head or brain; without contrast material	1.5%	14,788	11,798	$1.25M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.5%	22,939	20,696	$1.23M
G0378	Hospital observation service, per hour	1.3%	50,306	20,240	$1.05M

554 more codes

74177	Computed tomography, abdomen and pelvis; with contrast material	1.3%	7,736	$1.03M
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.3%	10,797	$1.02M
42820	Tonsillectomy and adenoidectomy; younger than age 12	1.1%	1,244	$888K
54161		1.1%	1,653	$862K
36415	Collection of venous blood by venipuncture	<1%	57,411	$748K
99285	Emergency room visit (most serious)	<1%	14,408	$696K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	22,377	$678K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	143,564	$676K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	12,354	$658K
71046	Radiologic examination, chest; 2 views	<1%	29,103	$632K
80048	Basic metabolic panel (calcium, ionized)	<1%	53,313	$632K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	13,255	$610K
87088		<1%	37,154	$609K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	1,617	$601K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	8,757	$519K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	4,434	$488K
99214	Doctor's office visit, returning patient (more involved)	<1%	20,817	$457K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,016	$456K
J9271	Injection, pembrolizumab, 1 mg	<1%	277	$442K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,133	$423K
T1015	A visit at a community health center or clinic (one all-in rate)	<1%	9,076	$416K
85027		<1%	16,511	$401K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	4,178	$399K
87631		<1%	7,891	$397K
84702		<1%	35,833	$358K
86850		<1%	10,848	$335K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	23,465	$300K
82962		<1%	27,400	$299K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	6,353	$293K
A9576	Injection, gadoteridol, (prohance multipack), per ml	<1%	3,125	$293K
H2019	Therapeutic behavioral services, billed per 15 minutes	<1%	5,304	$290K
42830		<1%	255	$281K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,426	$281K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,303	$278K
76770		<1%	3,504	$274K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	15,114	$263K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	8,398	$263K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	40,421	$238K
96375	Therapeutic injection; each additional sequential IV push	<1%	23,875	$235K
81001		<1%	50,110	$233K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	1,626	$232K
96401		<1%	2,003	$231K
92526		<1%	3,684	$225K
97161		<1%	2,681	$217K
71045	Radiologic examination, chest; single view	<1%	31,425	$216K
86900		<1%	12,515	$213K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	55,030	$212K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	9,694	$212K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	10,952	$191K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,312	$187K
96402		<1%	905	$182K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,832	$180K
76641		<1%	2,711	$180K
99213	Doctor's office visit, returning patient (routine)	<1%	7,030	$177K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	8,604	$176K
84484		<1%	29,781	$173K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	482	$165K
73610		<1%	2,836	$164K
81003		<1%	23,157	$159K
76819	Fetal biophysical profile; without non-stress testing	<1%	4,170	$158K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,295	$154K
44970		<1%	57	$152K
83880		<1%	4,758	$149K
95819		<1%	947	$147K
87486		<1%	9,384	$137K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	22,632	$125K
76882		<1%	2,004	$124K
96367		<1%	3,397	$124K
76801		<1%	6,579	$124K
85610		<1%	20,733	$123K
73562		<1%	4,109	$123K
73130		<1%	2,336	$122K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	9,160	$122K
84443	Thyroid stimulating hormone (TSH)	<1%	11,230	$120K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	17,507	$120K
92523		<1%	857	$119K
96415		<1%	2,523	$116K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	24,906	$110K
87186		<1%	6,741	$108K
72125	Computed tomography, cervical spine; without contrast material	<1%	4,244	$108K
54150		<1%	287	$105K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	325	$105K
H1000	Prenatal care, at-risk assessment	<1%	6,413	$103K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	10,767	$103K
83735		<1%	16,133	$102K
83970		<1%	1,968	$101K
85730		<1%	14,595	$100K
73110		<1%	1,980	$100K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	3,095	$99K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,443	$99K
73140		<1%	1,446	$98K
97162		<1%	1,022	$94K
95714		<1%	669	$94K
86901		<1%	12,532	$92K
86140		<1%	13,748	$90K
J1756	Injection, iron sucrose, 1 mg	<1%	2,495	$90K
74021		<1%	2,053	$89K
95713		<1%	516	$88K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	14,055	$87K
83690		<1%	23,882	$87K
00731		<1%	512	$87K
95782		<1%	256	$86K
87040		<1%	13,942	$85K
73630		<1%	2,950	$85K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	6,248	$84K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	20,108	$83K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	10,099	$82K
74019		<1%	5,604	$82K
J2704	Injection, propofol, 10 mg	<1%	25,195	$82K
93976		<1%	3,353	$80K
70486		<1%	1,402	$77K
73080		<1%	1,570	$77K
80197		<1%	6,507	$74K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	2,905	$74K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	11,849	$73K
72141		<1%	1,100	$73K
86359		<1%	1,844	$71K
77412		<1%	161	$71K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,484	$71K
95716		<1%	215	$68K
82728		<1%	5,671	$68K
84100		<1%	8,961	$66K
82570		<1%	7,996	$65K
81025		<1%	4,639	$63K
76377		<1%	997	$63K
70491		<1%	490	$62K
93975		<1%	664	$62K
97166		<1%	423	$62K
76830	Ultrasound, transvaginal	<1%	2,737	$60K
73090		<1%	1,337	$60K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	844	$60K
80061	Lipid panel	<1%	7,973	$59K
86902		<1%	1,628	$59K
82330		<1%	4,153	$58K
93970		<1%	1,501	$58K
82805		<1%	2,336	$58K
36430		<1%	1,415	$58K
J2505	Injection, pegfilgrastim, 6 mg	<1%	131	$58K
85045		<1%	6,211	$57K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	638	$57K
73030		<1%	2,401	$56K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	157	$56K
76000		<1%	1,985	$56K
76870		<1%	1,175	$56K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	5,189	$52K
J0690	Injection, cefazolin sodium, 500 mg	<1%	7,742	$52K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	8,370	$52K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	1,381	$49K
95951		<1%	587	$49K
J1453	Injection, fosaprepitant, 1 mg	<1%	948	$49K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	5,659	$48K
80076		<1%	7,656	$47K
88341		<1%	1,507	$47K
96409		<1%	1,216	$47K
74018		<1%	3,239	$47K
84156		<1%	6,332	$46K
88304		<1%	2,614	$46K
95812		<1%	171	$46K
92588		<1%	1,110	$45K
77072		<1%	1,091	$45K
83615		<1%	7,374	$45K
83550		<1%	3,716	$43K
82378		<1%	2,170	$43K
72146		<1%	600	$43K
36592		<1%	535	$43K
92550		<1%	948	$43K
83540		<1%	3,891	$42K
76885		<1%	447	$42K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	5,019	$42K
70544		<1%	969	$42K
73590		<1%	1,419	$41K
J2060	Injection, lorazepam, 2 mg	<1%	4,070	$41K
77336		<1%	1,012	$40K
87507		<1%	1,547	$39K
86923		<1%	2,252	$39K
87077		<1%	7,718	$38K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	427	$38K
93971		<1%	2,117	$37K
71250		<1%	1,727	$37K
77386		<1%	171	$37K
85384		<1%	1,604	$36K
83605		<1%	6,506	$36K
83036	Hemoglobin; glycosylated (A1C)	<1%	8,229	$36K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	9,396	$36K
82784		<1%	2,277	$35K
87210		<1%	4,465	$35K
87581		<1%	9,377	$35K
93798		<1%	593	$35K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,819	$34K
87799		<1%	4,929	$33K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,852	$33K
92587		<1%	672	$33K
82607		<1%	2,357	$32K
C1769	Guide wire	<1%	1,352	$32K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	342	$32K
77066	Tomosynthesis, mammo	<1%	946	$31K
87184		<1%	1,051	$30K
73522		<1%	862	$29K
84132		<1%	3,595	$27K
77387		<1%	43	$26K
72040		<1%	785	$26K
72131		<1%	690	$25K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,193	$25K
84550		<1%	2,180	$25K
86403		<1%	1,437	$25K
75561		<1%	102	$25K
74230		<1%	451	$24K
84439		<1%	5,086	$24K
96411		<1%	1,171	$24K
10060		<1%	1,102	$23K
92567		<1%	1,515	$23K
82550		<1%	3,821	$23K
87522	Neg quan hep c or qual rna	<1%	1,622	$23K
96417		<1%	1,348	$23K
83020		<1%	4,419	$23K
87340		<1%	3,106	$22K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	478	$22K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	11,109	$22K
80069		<1%	1,355	$22K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	537	$22K
88342		<1%	2,785	$21K
88307		<1%	1,004	$21K
89051		<1%	783	$21K
87070		<1%	3,461	$21K
73620		<1%	504	$20K
72100		<1%	1,658	$20K
82803		<1%	962	$19K
94010		<1%	1,661	$19K
87497		<1%	3,665	$19K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	498	$19K
85379		<1%	3,009	$19K
92557		<1%	203	$19K
82247		<1%	917	$18K
97535	Self-care/home management training, each 15 minutes	<1%	630	$18K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,105	$18K
93325		<1%	2,003	$17K
84112		<1%	395	$17K
82610		<1%	1,416	$16K
84295		<1%	2,775	$16K
85651		<1%	6,784	$15K
86780		<1%	2,632	$15K
99215	Doctor's office visit, returning patient (complex)	<1%	530	$15K
C9113	Injection, pantoprazole sodium, per vial	<1%	3,184	$15K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	4,468	$15K
97803		<1%	170	$15K
92652		<1%	263	$14K
G1010	Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program	<1%	17,928	$14K
00813		<1%	90	$14K
94760		<1%	5,397	$13K
J1170	Injection, hydromorphone, up to 4 mg	<1%	8,083	$13K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,953	$13K
86300		<1%	411	$13K
82947		<1%	2,023	$13K
T1030	Nursing care, in the home, by registered nurse, per diem	<1%	494	$13K
72170		<1%	1,849	$13K
97802		<1%	136	$13K
36591		<1%	2,793	$12K
80074		<1%	381	$12K
82435		<1%	1,992	$12K
01922		<1%	335	$12K
82272		<1%	637	$12K
12011		<1%	1,920	$11K
73502		<1%	1,113	$11K
70250		<1%	171	$11K
85014		<1%	2,683	$11K
70547		<1%	271	$10K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,154	$10K
87205		<1%	2,959	$10K
74246		<1%	179	$10K
96523		<1%	748	$10K
76536		<1%	156	$10K
92585		<1%	171	$10K
12001		<1%	1,213	$10K
82105		<1%	667	$10K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,692	$10K
G0390	Trauma response team associated with hospital critical care service	<1%	64	$10K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,834	$10K
77062		<1%	566	$10K
86663		<1%	218	$9K
49585		<1%	14	$9K
77080		<1%	348	$9K
99157		<1%	1,356	$9K
96377		<1%	71	$9K
73660		<1%	134	$9K
82951		<1%	479	$8K
82248		<1%	2,347	$8K
84145		<1%	1,760	$8K
80299		<1%	2,279	$8K
92579		<1%	830	$8K
59025	Fetal non-stress test	<1%	117	$8K
J1953	Injection, levetiracetam, 10 mg	<1%	771	$8K
82140		<1%	566	$8K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	628	$8K
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	612	$7K
97163		<1%	56	$7K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,369	$7K
J2997	Injection, alteplase recombinant, 1 mg	<1%	266	$7K
J1630	Injection, haloperidol, up to 5 mg	<1%	1,274	$7K
73552		<1%	427	$7K
96376		<1%	4,244	$7K
93886		<1%	63	$7K
86360		<1%	1,811	$7K
85018		<1%	1,769	$7K
70496		<1%	36	$6K
92610		<1%	74	$6K
62270		<1%	167	$6K
86922		<1%	1,177	$6K
H2000	Comprehensive multidisciplinary evaluation	<1%	34	$6K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	35	$6K
36600		<1%	698	$6K
87075		<1%	730	$6K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,216	$6K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	423	$6K
86021		<1%	1,367	$6K
82746		<1%	1,383	$6K
87536		<1%	1,461	$6K
86003		<1%	382	$5K
36416		<1%	205	$5K
J0897	Injection, denosumab, 1 mg	<1%	37	$5K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	56	$5K
85660		<1%	995	$5K
88313		<1%	633	$5K
12002		<1%	276	$5K
83516		<1%	656	$5K
00300		<1%	503	$5K
86870		<1%	144	$5K
00400		<1%	544	$5K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	4,741	$5K
76010		<1%	109	$5K
77334		<1%	65	$5K
J1940	Injection, furosemide, up to 20 mg	<1%	1,491	$5K
80165		<1%	651	$5K
86787		<1%	525	$4K
29125		<1%	1,229	$4K
86301		<1%	68	$4K
90715		<1%	1,685	$4K
81002		<1%	6,512	$4K
70260		<1%	73	$4K
86762		<1%	570	$4K
72070		<1%	257	$4K
74174		<1%	14	$4K
85347		<1%	747	$4K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	361	$4K
97116		<1%	581	$4K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	963	$4K
96368		<1%	17	$4K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	277	$4K
82150		<1%	1,746	$4K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	188	$4K
43762		<1%	222	$4K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	147	$3K
82043		<1%	1,486	$3K
49083		<1%	62	$3K
J8540	Dexamethasone, oral, 0.25 mg	<1%	11,202	$3K
76942		<1%	384	$3K
H0031	Mental health assessment, by non-physician	<1%	69	$3K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	72	$3K
84146		<1%	235	$3K
77300		<1%	70	$3K
84153		<1%	563	$3K
86038		<1%	377	$3K
95700		<1%	356	$3K
97165		<1%	50	$3K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	144	$3K
86376		<1%	149	$3K
86336		<1%	122	$3K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	167	$3K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	12	$3K
93320		<1%	1,913	$3K
70360		<1%	85	$3K
72156		<1%	13	$3K
73000		<1%	42	$3K
88185		<1%	153	$2K
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	1,227	$2K
95712		<1%	14	$2K
86160		<1%	322	$2K
73060		<1%	155	$2K
94667		<1%	77	$2K
29515		<1%	1,089	$2K
86833		<1%	1,118	$2K
88344		<1%	80	$2K
82677		<1%	122	$2K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	19	$2K
86665		<1%	386	$2K
86308		<1%	277	$2K
86832		<1%	1,117	$2K
72082		<1%	26	$2K
87449		<1%	115	$1K
86480		<1%	257	$1K
70480		<1%	13	$1K
80305		<1%	157	$1K
86706		<1%	148	$1K
73700		<1%	32	$1K
99442		<1%	79	$1K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	87	$1K
84157		<1%	701	$1K
78306		<1%	12	$1K
82530		<1%	108	$1K
99155		<1%	1,178	$1K
87324		<1%	51	$998.99
84481		<1%	145	$997.70
80195		<1%	901	$990.94
76506		<1%	12	$916.06
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	135	$891.35
71100		<1%	30	$871.14
82945		<1%	647	$861.27
88108		<1%	419	$855.45
H0032	Mental health service plan development by non-physician	<1%	12	$851.60
29130		<1%	369	$840.58
94621		<1%	13	$830.82
82010		<1%	572	$816.93
77065	Tomosynthesis, mammo	<1%	33	$815.81
51701		<1%	2,003	$808.69
88184		<1%	137	$803.25
87147		<1%	15	$796.05
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	18	$762.35
H1001	Prenatal care, at-risk enhanced service; antepartum management	<1%	51	$752.00
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	155	$741.23
76775		<1%	13	$717.07
84165		<1%	42	$694.03
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	303	$669.45
96450		<1%	31	$660.42
86592		<1%	144	$656.00
83789		<1%	33	$653.42
92611		<1%	312	$621.08
92582		<1%	40	$592.43
76881		<1%	12	$550.30
87081		<1%	862	$546.85
J0461	Injection, atropine sulfate, 0.01 mg	<1%	43	$508.37
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	112	$499.96
70498		<1%	33	$491.82
J9206	Injection, irinotecan, 20 mg	<1%	33	$485.65
80143		<1%	679	$478.22
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	15	$463.60
J7510	Prednisolone oral, per 5 mg	<1%	1,486	$459.19
00170	Anesthesia for intraoral procedures, including biopsy	<1%	6,733	$448.32
43760		<1%	15	$430.76
99201		<1%	17	$421.34
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	142	$416.86
72193		<1%	43	$413.57
70487		<1%	13	$403.54
80184		<1%	13	$392.78
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	163	$365.95
80164		<1%	401	$361.74
83930		<1%	137	$338.50
86334		<1%	17	$337.48
83001		<1%	144	$332.21
81401		<1%	15	$326.78
86769		<1%	38	$307.23
84134		<1%	67	$305.40
J9267	Injection, paclitaxel, 1 mg	<1%	39	$295.35
24640		<1%	81	$285.34
74247		<1%	50	$280.95
73600		<1%	14	$275.33
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	76	$270.14
29105		<1%	292	$259.55
94727		<1%	29	$257.51
82525		<1%	84	$257.32
86704		<1%	138	$256.67
29505		<1%	118	$236.17
84311		<1%	341	$235.98
J9370	Vincristine sulfate, 1 mg	<1%	684	$235.27
84403		<1%	180	$232.38
Q0243	Injection, casirivimab and imdevimab, 2400 mg	<1%	25	$216.23
91300		<1%	46	$207.79
82670		<1%	29	$199.35
J9250	Methotrexate sodium, 5 mg	<1%	72	$190.32
82785		<1%	101	$176.52
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	189	$172.14
J2780	Injection, ranitidine hydrochloride, 25 mg	<1%	60	$165.71
83010		<1%	35	$138.63
82977		<1%	621	$133.83
84300		<1%	14	$133.16
90658		<1%	53	$127.65
83655		<1%	89	$127.13
94729		<1%	14	$125.00
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	19	$116.38
84480		<1%	104	$115.82
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	23	$112.25
86664		<1%	217	$104.32
92555		<1%	62	$103.62
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	28	$103.15
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	13	$97.98
85046		<1%	250	$97.39
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	14	$94.41
81243		<1%	23	$89.08
84305		<1%	309	$84.77
93356		<1%	688	$84.34
C1889	Implantable/insertable device, not otherwise classified	<1%	33	$70.59
77001		<1%	107	$70.14
90686		<1%	161	$68.88
87181		<1%	227	$68.56
88311		<1%	144	$56.63
00840		<1%	410	$46.76
83002		<1%	154	$43.50
83519		<1%	62	$38.72
85576		<1%	15	$38.58
J0780	Injection, prochlorperazine, up to 10 mg	<1%	97	$35.07
29530		<1%	27	$35.07
00126		<1%	464	$23.79
77061		<1%	12	$23.46
72128		<1%	29	$23.38
86317		<1%	39	$20.53
3044F		<1%	778	$20.00
82340		<1%	13	$16.74
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	124	$16.47
00920		<1%	1,361	$16.12
86800		<1%	31	$15.82
80179		<1%	596	$14.65
J0290	Injection, ampicillin sodium, 500 mg	<1%	53	$11.69
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	32	$11.69
88312		<1%	13	$11.64
82652		<1%	41	$8.49
0002A		<1%	57	$3.36
87102		<1%	35	$2.28
G8510	Screening for depression is documented as negative, a follow-up plan is not required	0%	11,678	$0.00
3008F		0%	4,808	$0.00
1126F		0%	4,113	$0.00
L8699	Prosthetic implant, not otherwise specified	0%	361	$0.00
G0299	Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes	0%	434	$0.00
3351F		0%	9,021	$0.00
1170F		0%	740	$0.00
3074F		0%	1,357	$0.00
Q5001	Hospice or home health care provided in patient's home/residence	0%	337	$0.00
G0151	Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes	0%	240	$0.00
1123F		0%	13	$0.00
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	0%	16	$0.00
1111F		0%	429	$0.00
0001A		0%	42	$0.00
G0300	Direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting, each 15 minutes	0%	321	$0.00
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	0%	13	$0.00
00120		0%	12	$0.00
1125F		0%	273	$0.00
G0157	Services performed by a qualified physical therapist assistant in the home health or hospice setting, each 15 minutes	0%	283	$0.00
01400		0%	30	$0.00
G0152	Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes	0%	59	$0.00
97010		0%	26	$0.00
00790		0%	13	$0.00
83825		0%	12	$0.00
3079F		0%	15	$0.00
G0008	Administration of influenza virus vaccine	0%	16	$0.00
3075F		0%	12	$0.00
J9045	Injection, carboplatin, 50 mg	0%	25	$0.00
3725F		0%	14,203	$0.00
3078F		0%	1,585	$0.00
1159F		0%	306	$0.00
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	0%	650	$0.00
82175		0%	12	$0.00
01926		0%	12	$0.00
1160F		0%	290	$0.00
99080		0%	25	$0.00
69200		0%	40	$0.00
76376		0%	17	$0.00
76857		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBURNS, MELISSA (DIRECTOR)

Same official

Other billing entities under BURNS, MELISSA

Full network →

Provider	Location	Paid
South Broward Hospital District	Pembroke Pines, FL	$22.75M
South Broward Hospital District	Pembroke Pines, FL	$14.98M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.